EODData

MEMBERSHIP REGISTER LOG IN

FRA, PX91: Cassava Sciences Inc

15 Sep 2025
LAST:

1.770

CHANGE:
 0.04		OPEN:
1.770		HIGH:
1.770		ASK:
0.000		VOLUME:
14
CHG(%):
2.37		PREV:
1.813		LOW:
1.770		BID:
0.000		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
15 Sep 251.7701.7701.7701.77014
12 Sep 251.8131.8131.8131.81314
11 Sep 251.7671.7671.7671.76714
10 Sep 251.8341.8341.8341.83414
09 Sep 251.7891.7891.7891.78914
08 Sep 251.8311.8311.8311.83114
05 Sep 251.8311.8311.8311.83114
04 Sep 251.8661.8661.8661.86614
03 Sep 251.9221.9221.9221.92214
02 Sep 251.9131.9131.9131.91314

COMPANY PROFILE

Name:Cassava Sciences Inc
About:Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2 clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's disease. Cassava Sciences, Inc. was formerly known as Pain Therapeutics, Inc. and changed its name to Cassava Sciences, Inc. in March 2019. The company was incorporated in 1998 and is based in Austin, Texas.
Sector:Healthcare
Industry:Biotechnology
Address:6801 N. Capital of Texas Highway, Austin, TX, United States, 78731
Website:https://www.cassavasciences.com
ISIN:US14817C1071
LEI:529900XA0UG5JXABYF08

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

TECHNICAL INDICATORS

MA5:1.79
MA10:1.83
MA20:1.86
MA50:1.89
MA100:1.78
MA200:2.03
STO9:1.94
STO14:1.28
RSI14:46.18
WPR14:-98.72
MTM14:-0.22
ROC14:-0.11
ATR:0.05
Week High:1.83
Week Low:1.77
Month High:2.03
Month Low:1.77
Year High:34.19
Year Low:1.03
Volatility:50.80

RECENT SPLITS

Date Ratio
10 May 20171-7